Aligos Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALGS and other ETFs, options, and stocks.

About ALGS

Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is engaged in in developing therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). 

CEO
Lawrence M. Blatt
CEOLawrence M. Blatt
Employees
66
Employees66
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2018
Founded2018
Employees
66
Employees66

ALGS Key Statistics

Market cap
85.18M
Market cap85.18M
Price-Earnings ratio
-1.78
Price-Earnings ratio-1.78
Dividend yield
—
Dividend yield—
Average volume
241.52K
Average volume241.52K
High today
$25.20
High today$25.20
Low today
$23.24
Low today$23.24
Open price
$24.20
Open price$24.20
Volume
267.10K
Volume267.10K
52 Week high
$46.80
52 Week high$46.80
52 Week low
$6.76
52 Week low$6.76
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.